Skip to main content
Top
Gepubliceerd in: Quality of Life Research 5/2023

19-11-2022 | Special Section: Methodologies for Meaningful Change

How strong should my anchor be for estimating group and individual level meaningful change? A simulation study assessing anchor correlation strength and the impact of sample size, distribution of change scores and methodology on establishing a true meaningful change threshold

Auteurs: Pip Griffiths, Joel Sims, Abi Williams, Nicola Williamson, David Cella, Elaine Brohan, Kim Cocks

Gepubliceerd in: Quality of Life Research | Uitgave 5/2023

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Purpose

Treatment benefit as assessed using clinical outcome assessments (COAs), is a key endpoint in many clinical trials at both the individual and group level. Anchor-based methods can aid interpretation of COA change scores beyond statistical significance, and help derive a meaningful change threshold (MCT). However, evidence-based guidance on the selection of appropriately related anchors is lacking.

Methods

A simulation was conducted which varied sample size, change score variability and anchor correlation strength to assess the impact of these variables on recovering the simulated MCT for interpreting individual and group-level results. To assess MCTs derived at the individual-level (i.e. responder definitions; RDs), Receiver Operating Characteristic (ROC) curves and Predictive Modelling (PM) analyses were conducted. To assess MCTs for interpreting change at the group-level, the mean change method was conducted.

Results

Sample sizes, change score variability and magnitude of anchor correlation affected accuracy of the estimated MCT. For individual-level RDs, ROC curves were less accurate than PM methods at recovering the true MCT. For both methods, smaller samples led to higher variability in the returned MCT, but higher variability still using ROC. Anchors with weaker correlations with COA change scores had increased variability in the estimated MCT. An anchor correlation of around 0.50–0.60 identified a true MCT cut-point under certain conditions using ROC. However, anchor correlations as low as 0.30 were appropriate when using PM under certain conditions. For interpreting group-level results, the MCT derived using the mean change method was consistently underestimated regardless of the anchor correlation.

Conclusion

Sample size and change score variability influence the necessary anchor correlation strength when recovering individual-level RDs. Often, this needs to be higher than the commonly accepted threshold of 0.30. Stronger correlations than 0.30 are required when using the mean change method. Results can assist researchers selecting and assessing the quality of anchors.
Bijlagen
Alleen toegankelijk voor geautoriseerde gebruikers
Literatuur
1.
go back to reference Coon, C. D., & Cappelleri, J. C. (2016). Interpreting change in scores on patient-reported outcome instruments. Therapeutic Innovation & Regulatory Science, 50(1), 22–29.CrossRef Coon, C. D., & Cappelleri, J. C. (2016). Interpreting change in scores on patient-reported outcome instruments. Therapeutic Innovation & Regulatory Science, 50(1), 22–29.CrossRef
2.
go back to reference Revicki, D. H. R., Cella, D., & Sloan, J. (2008). Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. Clinical Epidemiology, 61(2), 102–109.CrossRef Revicki, D. H. R., Cella, D., & Sloan, J. (2008). Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. Clinical Epidemiology, 61(2), 102–109.CrossRef
3.
go back to reference Food and Drug Administration. (2009) Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims. Food and Drug Administration. (2009) Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims.
4.
go back to reference Coon, C. D., & Cook, K. F. (2018). Moving from significance to real-world meaning: Methods for interpreting change in clinical outcome assessment scores. Quality of Life Research, 27(1), 33–40.CrossRefPubMed Coon, C. D., & Cook, K. F. (2018). Moving from significance to real-world meaning: Methods for interpreting change in clinical outcome assessment scores. Quality of Life Research, 27(1), 33–40.CrossRefPubMed
5.
go back to reference Terwee, C. B., Peipert, J. D., Chapman, R., Lai, J. S., Terluin, B., Cella, D., Griffith, P., & Mokkink, L. B. (2021). Minimal important change (MIC): a conceptual clarification and systematic review of MIC estimates of PROMIS measures. Quality of Life Research, 30(10), 2729–2754.CrossRefPubMedPubMedCentral Terwee, C. B., Peipert, J. D., Chapman, R., Lai, J. S., Terluin, B., Cella, D., Griffith, P., & Mokkink, L. B. (2021). Minimal important change (MIC): a conceptual clarification and systematic review of MIC estimates of PROMIS measures. Quality of Life Research, 30(10), 2729–2754.CrossRefPubMedPubMedCentral
6.
go back to reference Martin Bland, J., & Altman, D. (1986). Statistical methods for assessing agreement between two methods of clinical measurement. The Lancet, 327(8476), 307–310.CrossRef Martin Bland, J., & Altman, D. (1986). Statistical methods for assessing agreement between two methods of clinical measurement. The Lancet, 327(8476), 307–310.CrossRef
7.
go back to reference Food and Drug Administration. (2018) Patient-Focused Drug Development: Methods to Identify What is Important to Patients & Select, Develop or Modify Fit-for-Purpose Clinical Outcomes Assessments. Draft discussion document. Food and Drug Administration. (2018) Patient-Focused Drug Development: Methods to Identify What is Important to Patients & Select, Develop or Modify Fit-for-Purpose Clinical Outcomes Assessments. Draft discussion document.
8.
go back to reference Cohen, J. (2013). Statistical power analysis for the behavioral sciences. Academic press.CrossRef Cohen, J. (2013). Statistical power analysis for the behavioral sciences. Academic press.CrossRef
9.
go back to reference Hays, R. D., Farivar, S. S., & Liu, H. (2005). Approaches and recommendations for estimating minimally important differences for health-related quality of life measures. COPD, 2(1), 63–67.CrossRefPubMed Hays, R. D., Farivar, S. S., & Liu, H. (2005). Approaches and recommendations for estimating minimally important differences for health-related quality of life measures. COPD, 2(1), 63–67.CrossRefPubMed
10.
go back to reference Guyatt, G. H., Norman, G. R., Juniper, E. F., & Griffith, L. E. (2002). A critical look at transition ratings. Journal of Clinical Epidemiology, 55(9), 900–908.CrossRefPubMed Guyatt, G. H., Norman, G. R., Juniper, E. F., & Griffith, L. E. (2002). A critical look at transition ratings. Journal of Clinical Epidemiology, 55(9), 900–908.CrossRefPubMed
11.
go back to reference Escobar, A., Garcia Perez, L., Herrera-Espineira, C., et al. (2013). Total knee replacement; minimal clinically important differences and responders. Osteoarthritis Cartilage, 21(12), 2006–2012.CrossRefPubMed Escobar, A., Garcia Perez, L., Herrera-Espineira, C., et al. (2013). Total knee replacement; minimal clinically important differences and responders. Osteoarthritis Cartilage, 21(12), 2006–2012.CrossRefPubMed
12.
go back to reference Devji, T., Carrasco-Labra, A., Qasim, A., Phillips, M., Johnston, B. C., Devasenapathy, N., Zeraatkar, D., Bhatt, M., Jin, X., Brignardello-Petersen, R., Urquhart, O., Foroutan, F., Schandelmaier, S., Pardo-Hernandez, H., Vernooij, R. W., Huang, H., Rizwan, Y., Siemieniuk, R., Lytvyn, L.,...Guyatt, G. H. (2020). Evaluating the credibility of anchor based estimates of minimal important differences for patient reported outcomes: instrument development and reliability study. BMJ, 2369, m1714.CrossRef Devji, T., Carrasco-Labra, A., Qasim, A., Phillips, M., Johnston, B. C., Devasenapathy, N., Zeraatkar, D., Bhatt, M., Jin, X., Brignardello-Petersen, R., Urquhart, O., Foroutan, F., Schandelmaier, S., Pardo-Hernandez, H., Vernooij, R. W., Huang, H., Rizwan, Y., Siemieniuk, R., Lytvyn, L.,...Guyatt, G. H. (2020). Evaluating the credibility of anchor based estimates of minimal important differences for patient reported outcomes: instrument development and reliability study. BMJ, 2369, m1714.CrossRef
13.
go back to reference Ousmen, A., Touraine, C., Deliu, N., Cottone, F., Bonnetain, F., Efficace, F., Brédart, A., Mollevi, C., & Anota, A. (2018). Distribution- and anchor-based methods to determine the minimally important difference on patient-reported outcome questionnaires in oncology: a structured review. Health Qual Life Outcomes, 16(1), 228.CrossRefPubMedPubMedCentral Ousmen, A., Touraine, C., Deliu, N., Cottone, F., Bonnetain, F., Efficace, F., Brédart, A., Mollevi, C., & Anota, A. (2018). Distribution- and anchor-based methods to determine the minimally important difference on patient-reported outcome questionnaires in oncology: a structured review. Health Qual Life Outcomes, 16(1), 228.CrossRefPubMedPubMedCentral
14.
go back to reference Fayers, P. M., & Hays, R. D. (2014). Don’t middle your MIDs: Regression to the mean shrinks estimates of minimally important differences. Quality of Life Research, 23(1), 1–4.CrossRefPubMed Fayers, P. M., & Hays, R. D. (2014). Don’t middle your MIDs: Regression to the mean shrinks estimates of minimally important differences. Quality of Life Research, 23(1), 1–4.CrossRefPubMed
15.
go back to reference Morris, T. P., White, I. R., & Crowther, M. J. (2019). Using simulation studies to evaluate statistical methods. Statistics in Medicine, 38(11), 2074–2102.CrossRefPubMedPubMedCentral Morris, T. P., White, I. R., & Crowther, M. J. (2019). Using simulation studies to evaluate statistical methods. Statistics in Medicine, 38(11), 2074–2102.CrossRefPubMedPubMedCentral
16.
go back to reference Terluin, B., Eekhout, I., Terwee, C. B., & de Vet, H. C. (2015). Minimal important change (MIC) based on a predictive modeling approach was more precise than MIC based on ROC analysis. Journal of Clinical Epidemiology, 68(12), 1388–1396.CrossRefPubMed Terluin, B., Eekhout, I., Terwee, C. B., & de Vet, H. C. (2015). Minimal important change (MIC) based on a predictive modeling approach was more precise than MIC based on ROC analysis. Journal of Clinical Epidemiology, 68(12), 1388–1396.CrossRefPubMed
17.
go back to reference Terluin, B., Griffiths, P., van der Wouden, J. C., Ingelsrud, L. H., & Terwee, C. B. (2020). Unlike ROC analysis, a new IRT method identified clinical thresholds unbiased by disease prevalence. Journal of Clinical Epidemiology, 124, 118–125.CrossRefPubMed Terluin, B., Griffiths, P., van der Wouden, J. C., Ingelsrud, L. H., & Terwee, C. B. (2020). Unlike ROC analysis, a new IRT method identified clinical thresholds unbiased by disease prevalence. Journal of Clinical Epidemiology, 124, 118–125.CrossRefPubMed
Metagegevens
Titel
How strong should my anchor be for estimating group and individual level meaningful change? A simulation study assessing anchor correlation strength and the impact of sample size, distribution of change scores and methodology on establishing a true meaningful change threshold
Auteurs
Pip Griffiths
Joel Sims
Abi Williams
Nicola Williamson
David Cella
Elaine Brohan
Kim Cocks
Publicatiedatum
19-11-2022
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 5/2023
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-022-03286-w

Andere artikelen Uitgave 5/2023

Quality of Life Research 5/2023 Naar de uitgave